With artificial intelligence and automation use cases rapidly reshaping clinical development, the medical writing function is undergoing significant transformation. From automating plain language summaries to supporting regulatory authoring workflows, AI and automation offer the potential to enhance consistency, accelerate timelines, and ease resource constraints. But what does the rise of these emerging technologies mean for the future of medical writing, and how are roles evolving in response? 

Join MMS and TrialAssure for a 45-minute webinar exploring the evolving intersection of AI and medical writing. Our experts will examine the current landscape, share insights from real-world PLS and authoring use cases, and explore practical strategies for overcoming barriers to AI adoption. With human expertise firmly in the loop, this session will highlight how medical writing teams are leading the way in piloting and implementing AI use cases that are delivering value to trial sponsors in the here and now.  

Watch This Webinar To:  
  • Gain lessons learned from early AI and automation use cases in medical writing — and how to avoid common pitfalls
  • Understand how thoughtful implementation and fit-for-purpose strategies can enhance quality, consistency, and efficiency
  • Explore innovative approaches including PLS automation, AI-assisted authoring, and human-in-the-loop collaboration
  • Discuss how real-time tools and automation are transforming document workflows and regulatory submissions
  • Learn how AI and data science are shaping the future of medical writing roles, teams, and processes.
What You Will Learn:
  • How AI is already gaining traction in medical writing, and what’s next
  • Lessons learned from early adoption use cases, including PLS automation and AI-assisted authoring
  • How to address barriers to transformation and enable effective ‘human in the loop’ collaboration
  • Perspectives on how medical writing skillsets, teams, and processes will need to transform in the AI era
Who will benefit from attending?

This session is ideal for professionals involved in clinical development and medical writing, particularly those exploring the integration of AI and automation into their workflows. Attendees who will benefit most include:

  • Medical Writing Professionals
  • Chief Medical Officers
  • Clinical Operations and Clinical Development professionals
  • Program and Trial Leads
  • Data Managers
  • Biostatisticians
  • Clinical Scientists
  • Medical Directors
  • Regulatory Affairs professionals
  • Real-World Evidence (RWE) specialists
  • Data Scientists
FAQs

Who is this webinar for?
This webinar and panel discussion is designed for medical writing professionals, clinical development leaders, regulatory affairs specialists, and anyone interested in the evolving role of AI and automation in clinical documentation.

Will there be a recording available?
Yes, a recording will be shared with all registered attendees after the live session.

Where can I get more information on the content presented?
To connect with the presenters or learn more about the topics discussed, please email info@mmsholdings.com and our team will direct your inquiry to the appropriate expert.

Meet our speakers
James Newman
Director, Regulatory and Medical Writing
Teresa Cesena
Executive Director, Regulatory and Medical Writing
Lucy Sutton
Vice President, Account Management
Zach Weingarden
Director, AI Technology and Applications, Trial Assure

Register Now

Suggested For You

webinar

July 31st, 2025

Design, Data, and Decisions in Oncology Trials

webinar

April 30th, 2025

Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies

webinar

March 25th, 2025

Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

webinar

September 12th, 2024

No Stone Unturned: Optimizing the Use of Expedited Pathways and Oncology Center of Excellence Programs to Optimize Drug Development in Oncology

webinar

July 11th, 2024

The Rising Burden of Pharmacovigilance (PV) Requirements in Early Drug Development

webinar

June 26th, 2024

A Psychedelic Shift: Assessing the Potential for Nonmedical Use in a Changing Regulatory Landscape

webinar

March 26th, 2024

Type II Drug Master Files for Early-Stage, Small Molecule, Drug Development: Regulatory Management, Quality Considerations, and eCTD Submission

webinar

January 18th, 2024

Best Practices for Data Visualization in Pharma, presented by MMS Holdings Data Science leaders

webinar

January 18th, 2024

The Wisdom Study: Revolutionizing Breast Cancer Screening, Detection & Prevention

webinar

January 18th, 2024

Evolving Your FSP Relationships to Achieve Maximum Return